XENETIC BIOSCIENCES, INC. (XBIO) Proxy Statement (DEF 14A) details matters for the December 11, 2025 Annual Meeting, including the election of six directors and ratification of CBIZ CPAs P.C. as the FY 2025 independent auditor, replacing Marcum following an acquisition.
Shareholder votes will also address executive compensation (“Say on Pay”). Financial performance remains weak, evidenced by extremely poor Total Shareholder Return (TSR); a \(100 investment in late 2021 was valued at only \)30.93 by year-end 2024. The company continues to report Net Losses, although the loss narrowed to $3.9
...